Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
Bavaro DF, De Vito A, Pasculli G, Bouba Y, Magnasco L, Pincino R, Saladini F, Lattanzio R, Corsini R, Arima S, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Vanni B, Di Biagio A. Bavaro DF, et al. J Med Virol. 2022 Aug;94(8):3890-3899. doi: 10.1002/jmv.27754. Epub 2022 Apr 9. J Med Virol. 2022. PMID: 35355293 Free PMC article.
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort.
Bavaro DF, Di Carlo D, Zuccalà P, Bai F, Incardona F, Battisti A, Giachè S, Salomoni E, Gagliardini R, Di Giambenedetto S, Pecorari M, Zazzi M, De Luca A, Bezenchek A, Lo Caputo S. Bavaro DF, et al. Infect Dis (Lond). 2019 Mar;51(3):234-239. doi: 10.1080/23744235.2018.1544423. Epub 2019 Jan 21. Infect Dis (Lond). 2019. PMID: 30663927 No abstract available.
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen.
Magnasco L, Pincino R, Pasculli G, Bouba Y, Saladini F, Bavaro DF, De Vito A, Lattanzio R, Corsini R, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Borghi V, Di Biagio A. Magnasco L, et al. Among authors: bavaro df. AIDS Res Hum Retroviruses. 2022 Jun;38(6):463-471. doi: 10.1089/AID.2021.0016. Epub 2022 Feb 10. AIDS Res Hum Retroviruses. 2022. PMID: 34969260
Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients.
Papagni R, Pellegrino C, Di Gennaro F, Patti G, Ricciardi A, Novara R, Cotugno S, Musso M, Guido G, Ronga L, Stolfa S, Bavaro DF, Romanelli F, Totaro V, Lattanzio R, De Iaco G, Palmieri F, Saracino A, Gualano G. Papagni R, et al. Among authors: bavaro df. Int J Mol Sci. 2022 Mar 31;23(7):3860. doi: 10.3390/ijms23073860. Int J Mol Sci. 2022. PMID: 35409219 Free PMC article. Review.
Predictors for Pulmonary Tuberculosis Outcome and Adverse Events in an Italian Referral Hospital: A Nine-Year Retrospective Study (2013-2021).
Di Gennaro F, Lattanzio R, Guido G, Ricciardi A, Novara R, Patti G, Cotugno S, De Vita E, Brindicci G, Mariano MF, Ronga L, Santoro CR, Romanelli F, Stolfa S, Papagni R, Bavaro DF, De Iaco G, Saracino A. Di Gennaro F, et al. Among authors: bavaro df. Ann Glob Health. 2022 Apr 26;88(1):26. doi: 10.5334/aogh.3677. eCollection 2022. Ann Glob Health. 2022. PMID: 35582409 Free PMC article.
84 results